Search Results - "van Boheemen, Laurette"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Predicting Rheumatoid Arthritis in At-risk Individuals by van Boheemen, Laurette, van Schaardenburg, Dirkjan

    Published in Clinical therapeutics (01-07-2019)
    “…The typical evolution of rheumatoid arthritis (RA) is that a person with genetic risk factors develops autoantibodies and subclinical inflammation under…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Rheumatoid factor autoantibody repertoire profiling reveals distinct binding epitopes in health and autoimmunity by Oskam, Nienke, Ooijevaar-De Heer, Pleuni, Kos, Dorien, Jeremiasse, Jorn, van Boheemen, Laurette, Verstappen, Gwenny M, Kroese, Frans G M, van Schaardenburg, Dirkjan, Wolbink, Gertjan, Rispens, Theo

    Published in Annals of the rheumatic diseases (01-07-2023)
    “…Rheumatoid factors (RF) are one of the hallmark autoantibodies characteristic of rheumatoid arthritis (RA), and are frequently observed in other diseases and…”
    Get more information
    Journal Article
  5. 5

    Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study by Raadsen, Reinder, Dijkshoorn, Bas, van Boheemen, Laurette, ten Boekel, Edwin, van Kuijk, Arno W.R., Nurmohamed, Michael T.

    Published in Joint, bone, spine : revue du rhumatisme (01-05-2024)
    “…[Display omitted] •Pre-RA patients in this cohort had normal lipid profile and NT-proBNP levels at baseline, however alterations in these levels were already…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Cardiovascular risk in persons at risk of developing rheumatoid arthritis by van Boheemen, Laurette, van Beers-Tas, Marian H, Kroese, Johanna M, van de Stadt, Lotte A, van Schaardenburg, Dirkjan, Nurmohamed, Michael T

    Published in PloS one (03-08-2020)
    “…Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this…”
    Get full text
    Journal Article
  9. 9

    Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis by van Boheemen, Laurette, Bolt, Janne W, ter Wee, Marieke M, de Jong, Henriëtte M, van de Sande, Marleen G, van Schaardenburg, Dirkjan

    Published in Arthritis research & therapy (15-09-2020)
    “…Abstract Background Individuals at risk of developing rheumatoid arthritis (RA) may benefit from lifestyle or pharmacological interventions aimed at primary…”
    Get full text
    Journal Article
  10. 10

    How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators by van Boheemen, Laurette, ter Wee, Marieke M, Seppen, Bart, van Schaardenburg, Dirkjan

    Published in Rheumatic & musculoskeletal diseases open (01-03-2021)
    “…ObjectivesSeveral trials to test the efficacy of a pharmacological intervention aimed at primary prevention of rheumatoid arthritis (RA) are ongoing or have…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk by Oskam, Nienke, Ooijevaar-de Heer, Pleuni, Kos, Dorien, van Boheemen, Laurette, van Schaardenburg, Dirkjan, Wolbink, Gertjan, Rispens, Theo

    Published in Rheumatic & musculoskeletal diseases open (20-08-2024)
    “…ObjectiveRheumatoid arthritis (RA) is characterised by the presence of autoantibodies, among which those targeting the constant region of immunoglobulin G…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20